trial · primary record
Brelovitug (BJT-778)
Chronic Hepatitis D
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2029-03-30 |
| Primary endpoint | Proportion of participants with undetectable HDV RNA (<LLOQ Target not detected [TND]) |
| Registry ID | NCT07454837 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:08.553Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07454837
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.